510(k) Report

510(k) · Cleared

Cleared

BT-Tite One (BTICV1), BT-Tite Standard (Btivsm), BT-Tite CV2(BTICV2)

K073458510(k) TraditionalCleared Apr 4, 2008116-day reviewClass II21 CFR 872.3640

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Btlock Srl · DZE Implant, Endosseous, Root-Form

Cleared on Apr 4, 2008 as substantially equivalent to K041661 (Nobel Biocare Uas, Inc., 2004) and 1 other predicate after a 116-day review. Its family tree reaches back 8 generations to 1993. 2 later devices descend from it.

Decided
Apr 4, 2008
Review
116 days
Class
Class II
Product code
DZE
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K925765 (1993). 69 ancestors in all, the oldest K781060 (1978). 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2003: 2 other ancestors2002: 5 other ancestors1999: 3 other ancestors1998: 3 other ancestors1997: 5 other ancestors1996: 6 other ancestors1995: 4 other ancestors2001: 2 other ancestors2000: 3 other ancestors1994: 6 other ancestors1990: 5 other ancestors1989: 5 other ancestors1988: 1 other ancestor1987: 2 other ancestors1986: 2 other ancestors1992: 2 other ancestors1985: 1 other ancestor1982: 1 other ancestor1978: 1 other ancestor1993: 1 other ancestor2015: 1 descendant cleared2009: 1 descendant clearedK925765 · Branemark System Standard 3.75MM Fixture · Nobelpharma USA, Inc. · 1993K994376 · Frialit-2 3.4MM Steeped Cylinder Implant with Frios TPS Coating; Frialit-2 3.4MM Steeped Cylinder Implant with Frios HA · Friadent GmbH · 2000K014235 · Osseotite NT Dental Implants & Accessories · Implant Innovations, Inc. · 2002K022009 · 3I Implants; Osseotite Dental Implants; Osseotite NT Dental Implants · Implant Innovations, Inc. · 2002K031475 · Osseotite NT Certain Implants · Implant Innovations, Inc. · 2003K041402 · Modification to Osseotite NT Certain Implants · Implant Innovations, Inc. · 2004×2: 2 generations cleared close together, K051189 (2005), K051461 (2005) 19801990200020102020
  1. Root · 8 generations backK925765 Branemark System Standard 3.75MM FixtureNobelpharma USA, Inc. · 1993
  2. 7 generations backK994376 Frialit-2 3.4MM Steeped Cylinder Implant with Frios TPS Coating…Friadent GmbH · 2000
  3. 6 generations backK014235 Osseotite NT Dental Implants & AccessoriesImplant Innovations, Inc. · 2002
  4. 5 generations backK022009 3I Implants; Osseotite Dental Implants; Osseotite NT Dental ImplantsImplant Innovations, Inc. · 2002
  5. 4 generations backK031475 Osseotite NT Certain ImplantsImplant Innovations, Inc. · 2003
  6. 3 generations backK041402 Modification to Osseotite NT Certain ImplantsImplant Innovations, Inc. · 2004
  7. 2 generations backK051189 Prevail Dental ImplantsImplant Innovations, Inc. · 2005
  8. 1 generation backK051461 3I Osseotite Dental ImplantsImplant Innovations, Inc. · 2005
  9. This deviceK073458 BT-Tite One (BTICV1), BT-Tite Standard (Btivsm), BT-Tite CV2(BTICV2)Btlock Srl · 2008
  10. Descendant · cites it directly · 0 of its ownK133733 WINSIX Implant SystemBiosaf IN S.R.L. · 2015
  11. Descendant · cites it directly · 0 of its ownK083869 BT-Tite CV3, Mini Implant, Mini Single, Slot Implant, Model (S)…Btlock Srl · 2009

Most influential descendants

Showing 2 of 2 · See all
  • K133733WINSIX Implant SystemBiosaf IN S.R.L. · 2015 · cites it directly0descendants
  • K083869BT-Tite CV3, Mini Implant, Mini Single, Slot Implant, Model (S) Dddiii BTICV3, 1, and…Btlock Srl · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K925765Branemark System Standard 3.75MM FixtureNobelpharma USA, Inc.1993—
−7K994376Frialit-2 3.4MM Steeped Cylinder Implant with Frios TPS Coating; Frialit-2…Friadent GmbH2000—
−6K014235Osseotite NT Dental Implants & AccessoriesImplant Innovations, Inc.2002—
−5K0220093I Implants; Osseotite Dental Implants; Osseotite NT Dental ImplantsImplant Innovations, Inc.2002—
−4K031475Osseotite NT Certain ImplantsImplant Innovations, Inc.2003—
−3K041402Modification to Osseotite NT Certain ImplantsImplant Innovations, Inc.2004—
−2K051189Prevail Dental ImplantsImplant Innovations, Inc.2005—
−1K0514613I Osseotite Dental ImplantsImplant Innovations, Inc.2005—
0 (this device)K073458BT-Tite One (BTICV1), BT-Tite Standard (Btivsm), BT-Tite CV2(BTICV2)Btlock Srl2008—
+1K133733WINSIX Implant SystemBiosaf IN S.R.L.2015—
+1K083869BT-Tite CV3, Mini Implant, Mini Single, Slot Implant, Model (S) Dddiii BTICV3…Btlock Srl2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
197810
198210
198510
198620
198720
198810
198950
199050
199220
199310
199460
199540
199660
199750
199830
199930
200030
200120
200250
200320
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201510
FIG. 1 — Lineage of K073458, 1993–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DZE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DZE device

  1. #1 K211090 ZENEX Implant Systemscore 25.4 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K041661Nobel Biocare Endosseous Implants
Summary page 1
…re claiming substancial equivalence, according 807.92(a)(3), are the following: Reference# Device Name Manufacturer K041661 NOBEL BIOCARE NOBEL BIOCARE UAS ENDOS…
Nobel Biocare Uas, Inc.2004—
*K0514613I Osseotite Dental Implants
Summary page 1
…Manufacturer K041661 NOBEL BIOCARE NOBEL BIOCARE UAS ENDOSSEOUS IMPLANTS K051461 31 OSSEOTITE DENTAL IMPLANT INNOVATIONS INC.…
Implant Innovations, Inc.2005—

Also cleared against K041661: 7 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133733WINSIX Implant SystemBiosaf IN S.R.L.20150
K083869BT-Tite CV3, Mini Implant, Mini Single, Slot Implant, Model (S) Dddiii BTICV3, 1, and…Btlock Srl20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 4 companies; a new generation was cleared every 12 months on median.
  • 9 of the 69 ancestors have a recall of any class.
  • Of its descendants, K133733 (Biosaf IN S.R.L., 2015) has gone furthest, with 0 descendants of its own.
  • 7 other devices also cite its predicate K041661.

How does its category compare?

All DZE devices

DZE Implant, Endosseous, Root-Form: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · DZE

31in 2025

2007: 432008: 612009: 412010: 342011: 262012: 392013: 422014: 362015: 362016: 402017: 482018: 412019: 312020: 412021: 342022: 342023: 352024: 402025: 312026 (partial year): 15
2007high 61 (2008) · low 26 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DZE

184in 2025

2007: 107 days median2008: 118 days median2009: 110 days median2010: 162 days median2011: 194 days median2012: 174 days median2013: 195 days median2014: 265 days median2015: 215 days median2016: 219 days median2017: 223 days median2018: 200 days median2019: 231 days median2020: 230 days median2021: 182 days median2022: 243 days median2023: 248 days median2024: 222 days median2025: 184 days median2026 (partial year): 194 days median
2007high 265 (2014) · low 107 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DZE

1in 2025

2007: 112008: 42009: 32010: 32012: 112013: 12014: 72015: 32016: 152017: 42018: 42019: 82021: 62024: 12025: 12026 (partial year): 2
2007high 15 (2016) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DZE

465,788in 2025

2007: 2252008: 3932009: 1642010: 3602011: 3622012: 3582013: 3912014: 1,1242015: 2,8942016: 1,1162017: 9,7192018: 12,8922019: 167,0162020: 255,5242021: 479,6182022: 483,2242023: 537,5852024: 473,6292025: 465,788
2007high 537,585 (2023) · low 164 (2009)2025

MAUDE reports naming product code DZE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074310711225
2008611184393
2009411103164
2010341623360
2011261940362
20123917411358
2013421951391
20143626571,124
20153621532,894
201640219151,116
20174822349,719
201841200412,892
2019312318167,016
2020412300255,524
2021341826479,618
2022342430483,224
2023352480537,585
2024402221473,629
2025311841465,788
2026151942—

What is it indicated for?

BT-Tite Standard (or VSM) It is intended to be used in maxilla or mandible, and for every kind of reconstruction, preferably not immediately loaded. It is intended to be used in a single stage or two stage surgical procedure. BT-Tite One (or CV1) It is -intended to be used in maxilla or mandible, for extraction sites and where the implant would be immediately loaded. It is intended to be used in a single stage or two stage surgical procedure. BT-Tite CV2…

Read the full statement (146 words)

BT-Tite Standard (or VSM) It is intended to be used in maxilla or mandible, and for every kind of reconstruction, preferably not immediately loaded. It is intended to be used in a single stage or two stage surgical procedure.

BT-Tite One (or CV1) It is -intended to be used in maxilla or mandible, for extraction sites and where the implant would be immediately loaded. It is intended to be used in a single stage or two stage surgical procedure.

BT-Tite CV2 (or CV2) It is intended to be used in maxilla or mandible. It is indicated in any situation for extraction sites, where the implant would be immediately loaded and where the bone crest is stable. In case of post-extraction sites, it has to be inserted some millimetres under the bone. It is intended to be used in a single stage or two stage surgical procedure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K073458: BT-Tite One (BTICV1), BT-Tite Standard (Btivsm), BT-Tite CV2(BTICV2).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K073458

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026